CB Insights
Technology Market Intelligence
Technology Market Intelligence
CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute postoperative and chronic neuropathic pain (painful diabetic neuropathy). CT-044, CerSci's lead molecular asset, has demonstrated efficacy across a batte...Show all
Company (Acquired)
Phone: 214-306-6218
1601 Elm Street
Floor 33
Dallas, 75201
Texas, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compounds for pain treatment, compositions comprising same, and methods of using same | Dec 27, 2019 | Nov 24, 2020 | Patent |
| Ampk agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same | Aug 31, 2018 | Jun 30, 2020 | Patent |
| Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent | Mar 10, 2020 | Application | |
| Methods of treating pain with a thiazoline anti-hyperalgesic | Dec 19, 2019 | Application | |
| Methods of treating diabetic neuropathy with a thiazoline anti-hyperalgesic agent | Oct 16, 2019 | Application |
